Vor Bio to Participate in the Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
(NASDAQ:VOR), CAMBRIDGE, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1×1 investor meetings at the Oppenheimer's 35th Annual Healthcare Life Sciences Conference. Oppenheimer's 35th Annual Healthcare Life Sciences ConferenceFireside Chat: Wednesday, February […]